##  [ESG](/au-en/esg "ESG") 

 As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.

 

 [ 

 ![Finance Forum ](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2024-07/58_300dpi_RGB.jpg.webp?itok=7Z4GMBbQ "Finance Forum ") 

 

###  Financial Transparency for Australia 

The new Medicines Australia Code of Conduct will increase transparency about the vital role of healthcare professionals in the development and use of new, innovative medicines.

 

 

 ](/au-en/esg/financial-transparency-australia) [ 

 ![View from Auckland's freeway, New Zealand.](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Financial%20Transparency%20for%20New%20Zealand.jpg.webp?itok=F8U1Xqdh "Financial Transparency for New Zealand") 

 

###  Financial Transparency for New Zealand 

The new Medicines New Zealand transparency guidelines will increase transparency about the vital role of healthcare professionals in the development and use of new, innovative medicines.

 

 

 ](/au-en/esg/financial-transparency-new-zealand) 





 [ 

 ![Patient with Doctor](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Grants.jpg.webp?itok=nfly50pC "Patient with Doctor") 

 

###  Grants 

Novartis provides funding opportunities for the general purposes of supporting healthcare initiatives from scientific and charitable organisations that directly support patients, improve healthcare and enable ongoing education that are aligned to our Therapeutic Areas.

 

 

 ](/au-en/esg/grants) [ 

 ![Team members connecting](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2024-07/568_300dpi_RGB.JPG.webp?itok=sKX9NBgP "Team members connecting") 

 

###  Diversity, Equity & Inclusion 

We embrace and champion diversity, equity and inclusion which fuels innovation, drives engagement and attracts talent.

 

 

 ](/au-en/esg/diversity-equity-inclusion) 





 [ 

 ![Patient](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Patient%20Groups.jpg.webp?itok=l3BYMXCq "Patient") 

 

###  Patient Groups 

Novartis is supporting patient groups. These groups play a vital role in educating and supporting patients and we remain mindful of their independent perspectives with regard to diseases and their related treatments.

 

 

 ](/au-en/esg/patient-groups) [ 

 ![Two businessman speaking](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Ethical%20Behaviour.jpg.webp?itok=JtBAFNvA "Ethical behavior") 

 

###  Ethical Behavior 

Our aim is to prevent issues from occurring, drive personal accountability for behaviors, and generate learnings that can be applied across the organization.

 

 

 ](/au-en/esg/ethical-behavior) 





 [ 

 ![People speaking around a table](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Ethics%2C%20Risk%20and%20Compliance.jpg.webp?itok=Ao__rnrm "Ethics, Risk and Compliance") 

 

###  Ethics, Risk and Compliance 

We recognize society’s expectations of our industry and of Novartis, and that we must go beyond just doing what is legal in order to meet legitimate expectations of society.

 

 

 ](https://www.novartis.com/esg/ethics-risk-and-compliance) [ 

 ![Doctor consulting a patient](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Access.jpg.webp?itok=6KFcSXdz "Access to medicines") 

 

###  Access to medicines 

We believe access to medicines is where we can have the greatest impact. For all our new medicines, we systematically integrate access strategies to reach underserved patients no matter where they live.

 

 

 ](https://www.novartis.com/esg/access) 





 [ 

 ![Trees](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Environmental%20Sustainability.jpg.webp?itok=FoI-DBU0 "Environmental Sustainability") 

 

###  Environmental Sustainability 

We understand the link between the health of our planet and the health of our patients. Our ambition is to be a catalyst for positive change and a leader in environmental sustainability.

 

 

 ](https://www.novartis.com/esg/environmental-sustainability) [ 

 ![Patient at the doctor](/au-en/sites/novartis_au/files/styles/cards_50_50/public/2022-12/Global%20Health.jpg.webp?itok=YmMl2IPw "Global Health") 

 

###  Global Health 

We apply our expertise and full organizational capability to address major, unresolved global health challenges.

 

 

 ](https://www.novartis.com/esg/global-health)